NASDAQ:AKBA
Akebia Therapeutics Stock News
$1.37
+0 (+0%)
At Close: Apr 24, 2024
AKBA Stock Price: Over 13% Increase Pre-Market Explanation
06:39am, Tuesday, 01'st Jun 2021
The stock price of Akebia Therapeutics Inc (NASDAQ: AKBA) increased by over 13% pre-market. This is why it happened.
CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney dis
Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options
09:01am, Tuesday, 25'th May 2021
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately.
These Reddit Penny Stocks Are Soaring Today, Are They Worth Buying?
01:31pm, Wednesday, 12'th May 2021
These Reddit penny stocks are climbing today; are they worth adding to your watchlist? The post These Reddit Penny Stocks Are Soaring Today, Are They Worth Buying?
New Strong Sell Stocks for May 12th
09:46am, Wednesday, 12'th May 2021
AKBA, CNA, EBMT, FCEL, and HMPT have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2021
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript
02:20pm, Monday, 10'th May 2021
Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript
Akebia Therapeutics (AKBA) Reports Q1 Loss, Tops Revenue Estimates
10:31am, Monday, 10'th May 2021
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -36.36% and 19.43%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
2 Falling Knives to Catch
02:14pm, Thursday, 06'th May 2021
Akebia Therapeutics Inc ( AKBA , Financial), Adverum Biotechnologies Inc ( ADVM , Financial) have performed so poorly over the prior 52 weeks through May 5, with the share prices losing more than 59%,
AKBA Stock: From $3.20 To Over $3.49 Pre-Market Explanation
06:19am, Thursday, 29'th Apr 2021
The stock price of Akebia Therapeutics Inc (NASDAQ: AKBA) increased from $3.20 to $3.49 as of 6:08 AM ET pre-market. This is why it happened.
CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today
Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights
08:00am, Wednesday, 28'th Apr 2021
CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today
NEW YORK, April 26, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 02'nd Apr 2021
CAMBRIDGE, Mass., April 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, grant
Akebia (AKBA) Files NDA for Vadadustat for Anemia Due to CKD
10:36am, Wednesday, 31'st Mar 2021
Akebia (AKBA) submits new drug application for vadadustat to treat anemia due to chronic kidney disease in adult patients who are on dialysis as well as who are not on dialysis.
CAMBRIDGE, Mass., March 30, 2021 /PRNewswire/ -- Akebia Therapeutics , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease,
